|
Volumn 34, Issue 2, 2002, Pages 665-667
|
Posttransplant adoptive immunotherapy with interleukin-2 in children suffering from neuroectodermal tumors with poor prognosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT INTERLEUKIN 2;
ADOLESCENT;
ADOPTIVE IMMUNOTHERAPY;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
FEASIBILITY STUDY;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MALE;
NATURAL KILLER CELL MEDIATED CYTOTOXICITY;
NEUROBLASTOMA;
NEUROECTODERM TUMOR;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
ADOLESCENT;
BONE MARROW TRANSPLANTATION;
BUSULFAN;
CHILD;
CHILD, PRESCHOOL;
CYTOTOXICITY, IMMUNOLOGIC;
GENE AMPLIFICATION;
GENES, MYC;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
INTERLEUKIN-2;
KILLER CELLS, NATURAL;
MELPHALAN;
NEUROECTODERMAL TUMORS;
PLATELET COUNT;
PROGNOSIS;
SEQUENCE DELETION;
TREATMENT OUTCOME;
|
EID: 0036264535
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02881-0 Document Type: Article |
Times cited : (2)
|
References (10)
|